Besides cancer cell lines, δ-tocotrienol inhibits the expression of pro-inflammatory markers such as IL-6 and NFκB in human umbilical vein endothelial cells (HUVECs) [77] and TNF-α, IL-6, and iNOS in macrophages [78]. The gene discussed is IL6; the disease is cancer.